Cargando…

Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature

BACKGROUND: Although fatigue is common in dialysis patients, polypharmacy is seldom listed among its causes. In this report, we describe a dialysis patient who developed severe fatigue due to pharmacological interaction between two commonly prescribed drugs, phosphate binders and levothyroxine. CASE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cataldo, Emanuela, Columbano, Valeria, Nielsen, Louise, Gendrot, Lurlynis, Covella, Bianca, Piccoli, Giorgina Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027573/ https://www.ncbi.nlm.nih.gov/pubmed/29966512 http://dx.doi.org/10.1186/s12882-018-0947-9

Ejemplares similares

Setting the clock back: new hope for dialysis patients. Sodium thiosulphate and the regression of vascular calcifications
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2020)

Positron Emission Tomography Can Support the Diagnosis of Dialysis-Related Amyloidosis
por: Santagati, Giulia, et al.
Publicado: (2019)

Prescribing Hemodialysis or Hemodiafiltration: When One Size Does Not Fit All the Proposal of a Personalized Approach Based on Comorbidity and Nutritional Status
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2018)

Intradialytic Nutrition and Hemodialysis Prescriptions: A Personalized Stepwise Approach
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2020)

Do we need new phosphate binders in dialysis?
por: Cozzolino, Mario, et al.
Publicado: (2020)

Phosphate binders in dialysis: better satisfied than sorry
por: Cozzolino, Mario, et al.
Publicado: (2021)

The “phosphorus pyramid”: a visual tool for dietary phosphate management in dialysis and CKD patients
por: D’Alessandro, Claudia, et al.
Publicado: (2015)

Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2023)

Incremental and Personalized Hemodialysis Start: A New Standard of Care
por: Torreggiani, Massimo, et al.
Publicado: (2022)

Green nephrology and eco-dialysis: a position statement by the Italian Society of Nephrology
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2020)

Interventional study to improve adherence to phosphate binder treatment in dialysis patients
por: Hjemås, Bodil Jahren, et al.
Publicado: (2019)

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
por: Floege, Jürgen, et al.
Publicado: (2015)

Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis
por: Tanaka, Akihito, et al.
Publicado: (2023)

Dialysis or a Plant-Based Diet in Advanced CKD in Pregnancy? A Case Report and Critical Appraisal of the Literature
por: Attini, Rossella, et al.
Publicado: (2019)

Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?
por: Negri, Armando Luis, et al.
Publicado: (2015)

Effectiveness and cost-efficiency of phosphate binders in hemodialysis
por: Fröschl, Barbara, et al.
Publicado: (2009)

Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells
por: Thiem, Ursula, et al.
Publicado: (2022)

Choice of the Dialysis Modality: Practical Considerations
por: Torreggiani, Massimo, et al.
Publicado: (2023)

The strange case of Mr. H. Starting dialysis at 90 years of age: clinical choices impact on ethical decisions
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2017)

Pharmacology of the Phosphate Binder, Lanthanum Carbonate
por: Damment, Stephen JP
Publicado: (2011)

The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management?
por: Cozzolino, Mario, et al.
Publicado: (2020)

A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients
por: Floege, Jürgen, et al.
Publicado: (2014)

Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study
por: Leung, Simon, et al.
Publicado: (2015)

New Intravenous Calcimimetic Agents: New Options, New Problems. An Example on How Clinical, Economical and Ethical Considerations Affect Choice of Treatment
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2020)

Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices?
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2019)

Spontaneous Renal Artery Dissection in Ehler–Danlos Syndrome
por: Emanuela, Cataldo, et al.
Publicado: (2019)

Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
por: Thet, Zaw, et al.
Publicado: (2013)

Cost-effectiveness of phosphate binders among patients with chronic kidney disease not yet on dialysis: a long way to go
por: Rizk, Rana
Publicado: (2016)

European hemodialysis patient satisfaction with phosphate binders is associated with serum phosphorus levels: the Dialysis Outcomes and Practice Patterns Study
por: McCullough, Keith, et al.
Publicado: (2021)

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide
por: Cernaro, Valeria, et al.
Publicado: (2016)

Preparation of acid aluminum phosphate solutions for metakaolin phosphate geopolymer binder
por: Yankwa Djobo, Jean Noël, et al.
Publicado: (2021)

Impact of phosphate binders on quality of life in dialysis patients: Results from the prospective Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes study
por: Colombijn, Julia M. T., et al.
Publicado: (2022)

The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2017)

Doxycycline treatment in dialysis related amyloidosis: discrepancy between antalgic effect and inflammation, studied with FDG-positron emission tomography: a case report
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2017)

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients
por: Farrand, Kimberly F, et al.
Publicado: (2014)

Adding creatinine to routine pregnancy tests: a decision tree for calculating the cost of identifying patients with CKD in pregnancy
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2022)

Tolerability and efficacy of the intestinal phosphate binder Lantharenol(® )in cats
por: Schmidt, Bernard H, et al.
Publicado: (2012)

The demise of calcium-based phosphate binders—is this appropriate for children?
por: Rees, Lesley, et al.
Publicado: (2014)

Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
por: Rodby, Roger A., et al.
Publicado: (2015)

Medical Nutritional Therapy for Patients with Chronic Kidney Disease not on Dialysis: The Low Protein Diet as a Medication
por: Cupisti, Adamasco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_380p9bvasoj0lgbde15u7u9d9t